These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12440991)

  • 21. Cellular delivery of hammerhead ribozymes conjugated to a transferrin receptor antibody.
    Hudson AJ; Normand N; Ackroyd J; Akhtar S
    Int J Pharm; 1999 May; 182(1):49-58. PubMed ID: 10332074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of ribozymes to HIV infection.
    Rossi JJ
    Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
    Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
    Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
    Langlois MA; Lee NS; Rossi JJ; Puymirat J
    Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
    Sun LQ; Wang L; Gerlach WL; Symonds G
    Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transport of intracellularly active ribozymes to the cytoplasm.
    Miyagishi M; Kuwabara T; Taira K
    Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S96-101. PubMed ID: 11587376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18.
    Chen Z; Kamath P; Zhang S; Weil MM; Shillitoe EJ
    Cancer Gene Ther; 1995 Dec; 2(4):263-71. PubMed ID: 8548580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribozymes as therapeutic tools for genetic disease.
    Phylactou LA; Kilpatrick MW; Wood MJ
    Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional colocalization of ribozymes and target mRNAs in Drosophila oocytes.
    Lee NS; Sun B; Williamson R; Gunkel N; Salvaterra PM; Rossi JJ
    FASEB J; 2001 Nov; 15(13):2390-400. PubMed ID: 11689464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences.
    Pachuk CJ; Yoon K; Moelling K; Coney LR
    Nucleic Acids Res; 1994 Feb; 22(3):301-7. PubMed ID: 8127665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization.
    Bertrand E; Castanotto D; Zhou C; Carbonnelle C; Lee NS; Good P; Chatterjee S; Grange T; Pictet R; Kohn D; Engelke D; Rossi JJ
    RNA; 1997 Jan; 3(1):75-88. PubMed ID: 8990401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes.
    Byun J; Lan N; Long M; Sullenger BA
    RNA; 2003 Oct; 9(10):1254-63. PubMed ID: 13130139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular ribozyme-catalyzed trans-cleavage of RNA monitored by fluorescence resonance energy transfer.
    Vitiello D; Pecchia DB; Burke JM
    RNA; 2000 Apr; 6(4):628-37. PubMed ID: 10786853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening effective target sites on mRNA: a ribozyme library approach.
    Unwalla HJ; Rossi JJ
    Methods Mol Biol; 2012; 848():329-36. PubMed ID: 22315078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method for prediction of accessible sites on an mRNA sequence for target selection of hammerhead ribozymes.
    Mercatanti A; Rainaldi G; Mariani L; Marangoni R; Citti L
    J Comput Biol; 2002; 9(4):641-53. PubMed ID: 12323098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
    Denman RB
    Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cleavage of AML1/MTG8 by asymmetric hammerhead ribozymes.
    Szyrach M; Münchberg FE; Riehle H; Nordheim A; Krauter J; Nagel S; Heil G; Heidenreich O
    Eur J Biochem; 2001 Jun; 268(12):3550-7. PubMed ID: 11422386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
    Ohkawa J; Yuyama N; Taira K
    Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
    Sullivan JM; Pietras KM; Shin BJ; Misasi JN
    Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.